ERBB2 and nonpapillary renal cell carcinoma: The data showed that the DFS of the ccRCC patients with SETD2 (Fig. 5A), BAP1 (Fig. 5B), PBRM1 (Fig. 5C), NPM1 (Fig. 6A), ERBB2 (Fig. 6B), CSFR1 (Fig. 6C), and ERBB3 (Fig. 6D) gene mutations were significant shorter than that of wild type patients over time.